Correspondence 0001493152-24-049440 from PALISADE BIO, INC. (PALI)
PALISADE BIO, INC.
Date: Dec. 10, 2024 · CIK: 0001357459 · Accession: 0001493152-24-049440
AI Filing Summary & Sentiment
File numbers found in text: 333-282883
Show Raw Text
CORRESP
1
filename1.htm
Ladenburg
Thalmann & Co. Inc.
640
Fifth Avenue, 4th Floor
New
York, New York 10019
December
10, 2024
VIA
EDGAR
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
DC 20549
Re:
Palisade
Bio, Inc.
Registration
Statement on Form S-1 (Registration No. 333-282883)
Concurrence
in Acceleration Request
Ladies
and Gentlemen:
Ladenburg
Thalmann & Co. Inc. (“Ladenburg”), as representative of the underwriters for the referenced offering, hereby concurs
in the request by Palisade Bio, Inc. that the effective date of the above-referenced registration statement be accelerated to 5:30 p.m.
(Eastern Time), or as soon as practicable thereafter, on December 11, 2024, pursuant to Rule 461 under the Securities Act. Ladenburg
affirms that it is aware of its obligations under the Securities Act in connection with this offering.
Very truly yours,
LADENBURG THALMANN & CO. INC.
By:
/s/
Nicholas Stergis
Name:
Nicholas
Stergis
Title:
Managing
Director